Tag: Part 11

Common Pitfalls in Validation & Part 11 Compliance—and How to Avoid Costly Disruptions The increasing reliance on digital technologies in clinical trials mandates that organizations adhere to stringent regulatory requirements. The compliance landscape is shaped by regulations from authorities such as the FDA, EMA, and MHRA, particularly concerning data integrity as articulated in 21 CFR…

Read More “Common Pitfalls in Validation & Part 11 Compliance—and How to Avoid Costly Disruptions” »

Aligning Validation & Part 11 Compliance With GCP, Privacy and Regulatory Expectations Aligning Validation & Part 11 Compliance With GCP, Privacy and Regulatory Expectations The intersection of regulatory compliance, data privacy, and Good Clinical Practice (GCP) has created a complex environment for biosimilar clinical trials and other research endeavors. As clinical operations, regulatory affairs, and…

Read More “Aligning Validation & Part 11 Compliance With GCP, Privacy and Regulatory Expectations” »

How to Select and Implement Validation & Part 11 Compliance That Scales Across Studies How to Select and Implement Validation & Part 11 Compliance That Scales Across Studies The regulatory landscape for clinical trials necessitates that organizations adhere to stringent guidelines to ensure data integrity and patient safety. This is particularly true when it comes…

Read More “How to Select and Implement Validation & Part 11 Compliance That Scales Across Studies” »

Validation & Part 11 Compliance in Practice: Step-by-Step Guide for Sponsors and CROs Validation & Part 11 Compliance in Practice: Step-by-Step Guide for Sponsors and CROs In the contemporary landscape of clinical trials, the importance of compliance with regulatory standards cannot be overstated. This is particularly true when it comes to the validation of electronic…

Read More “Validation & Part 11 Compliance in Practice: Step-by-Step Guide for Sponsors and CROs” »

Validation & Part 11 Compliance: Digital Strategy Blueprint for Modern Clinical Trials Validation & Part 11 Compliance: Digital Strategy Blueprint for Modern Clinical Trials The world of clinical trials is evolving rapidly. As the shift to digital systems increases, it becomes crucial for organizations to maintain compliance with regulatory frameworks such as the FDA’s Part…

Read More “Validation & Part 11 Compliance: Digital Strategy Blueprint for Modern Clinical Trials” »